References
- Bepler G, Carney D N, Nau M M, et al. Additive and differential biological activity of alpha-interferon A, difluoromethyl-ornithine, and their combination on established human lung cancer cell lines. Cancer Res 1986; 46: 3413–9
- Mattson K, Holsti L R, Niiranen A, et al. Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer. J Biol Resp Mod 1985; 4: 8–17
- Funa K, Gazdar A, Mattson K, et al. Interferon mediated in vivo induction of beta2-microglobulin on small cell lung cancers and mid-gut carcinoids. Clin Immunol Immunopathol 1986; 41: 159–64
- Ruff M R, Farrar W L, Pert CB. Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentation in small cell lung cancer cell lines. Proc Natl Acad Sci USA 1986; 8: 6613–7
- Mattson K, Niiranen A, Holsti L R, (1989) Natural alpha interferon as maintenance therapy for small cell lung cancer. The biology of the interferon system. 1988, Y Kawade, S Kobayashi, et al. Proc Fifth Annual Meeting of the Interferon Society for Interferon Research, KyotoJapan, 213–8
- Sarna G R, Figlin R, Callaghan M. Alpha (human leukocyte)—interferon as treatment for non-small cell carcinoma of the lung: A phase II trial. J Biol Resp Mod 1983; 2: 343–7
- Krown S, Stoopler M, Cunningham-Rundles S. Phase II trial of human leukocyte interferon (IF) in non-small cell lung cancer (NSCLC). Proc Am Assoc Cancer Res 1980; 21: 179
- Czarniecki C W, Fennie C W, Powers D B, et al. Synergistic antiviral and antiproliferative activities of E. coli-derived human alpha, beta and gamma interferons. J Virol 1984; 49: 490–6
- WHO handbook for reporting results of cancer treatment. WHO, Geneva 1979, Offset Pub No. 48.
- Quesada J R, Reuben J, Manning J T, et al. Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984; 310: 15–8
- Legha S. Interferons in the treatment of malignant melanoma. A review of recent trials. Cancer 1986; 57: 1675–7
- Neidhart JA. Interferon therapy for the treatment of renal cancer. Cancer 1986; 57: 1696–9
- Ettinger D S, Harwood K. Phase II study of recombinant beta interferon in patients with advanced non-small cell lung carcinoma. Med Pediatr Oncol 1988; 16: 30–2
- Gould M, Kakria R, Olson S, Borden E. Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J Interferon Res 1984; 4: 123–8
- Carmichael J, Ferguson R, Wolf R, et al. Augmentation of cytotoxicity of chemotherapy by human interferons in human non-small cell lung cancer xenografts. Cancer Res 1986; 46: 4916–29
- Smyth J, Ferguson R, Stewart M, et al. Alpha interferon potentiates cisplatin in patients with non-small cell lung cancer (NSCLC). Proc ASCO 1988; 7: 201
- Steiner A, Wolf C H, Pehamberger H. Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN-alpha, r-IFN-gamma and r-IFN-alpha + cimetidine) in disseminated malignant melanoma. J Cancer Res Clin Oncol 1987; 113: 459–65